Bristol Myers’ drug to treat intestinal disease misses key target in late-stage study -On March 28, 2024 at 9:05 p.m

Bristol Myers Squibb said Thursday that its experimental drug to treat Crohn’s disease, a chronic inflammatory bowel disease, failed to meet its main goal in a late-stage trial. (Reporting by Mariam Sunny in Bengaluru)